News

Caris Life Sciences Announces Presentations at AACR 2017 Annual Meeting Demonstrating the Broad Capabilities of ADAPT Biotargeting System

  Caris’ Novel Profiling Platform Facilitates a Deeper Understanding of Molecular Complexes to Support Drug Development and Advance Precision Medicine IRVING, Texas, Mar. 21, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced four abstracts that will be presented at the American Association … Continued

New Data in Nature’s Scientific Reports Shows Caris Life Sciences’ ADAPT Platform Detects Breast Cancer in Women via Liquid Biopsy of Circulating Exosomes

  Results Demonstrate Potential of Unprecedented Technology Approach to Classify Women Regardless of Breast Density IRVING, Texas, Feb. 21, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the results of a study that demonstrates the ability of the company’s ADAPT Biotargeting System™ … Continued

Caris Life Sciences and the Lustgarten Foundation Collaborate to Support Immunotherapy Clinical Trial for Pancreatic Cancer

Leveraging Precision Medicine to Evaluate Immunotherapy Opportunities for the Most Lethal Form of Cancer IRVING, Texas, Jan. 18, 2017 – Caris Life Sciences, a leading innovator in molecular science, and the Lustgarten Foundation, the largest private funder of pancreatic cancer research, are collaborating to support a clinical trial evaluating the impact of immunotherapy in the treatment … Continued

Caris Life Sciences Designates West Virginia University Cancer Institute a Caris Center of Excellence for Precision Medicine

West Virginia University Joins Precision Medicine Network to Broaden Access and Advance Clinical Utility of Tumor Profiling  IRVING, Texas, Nov. 3, 2016 – Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced the designation of the West Virginia University (WVU) Cancer Institute as a center of excellence site … Continued

Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris’ ADAPT Biotargeting System in the Development Program for Evofosfamide

Caris Life Sciences to Develop a Customized Assay for Pancreatic Cancer Patients to Predict Likelihood of Response to Evofosfamide, Threshold Pharmaceutical’s Lead Drug Product Candidate IRVING, Texas and SOUTH SAN FRANCISCO, Calif., Oct. 25, 2016 – Caris Life Sciences, a leading biotechnology company focused on fulfilling the promise of precision medicine, and Threshold Pharmaceuticals, Inc. … Continued

Caris Life Sciences to Present Key Research Findings at the European Society for Medical Oncology 2016 Congress

Comprehensive Tumor Profiling with Caris Molecular Intelligence Continues to Yield Molecular Insights to Enable the Delivery of Personalized Medicine  IRVING, Texas, Oct. 06, 2016 – Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine, announced today that the Company will deliver five poster presentations, including two poster discussions, at … Continued

Caris Life Sciences Announces Major Milestone of 100,000 Clinical Cases using Caris Molecular Intelligence

Precision Medicine Pioneer with Significant Achievements since 2008 IRVING, Texas, Aug. 29, 2016 – Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced that it has surpassed 100,000 clinical cases with its comprehensive genomic and proteomic tumor profiling offering, Caris Molecular Intelligence®. “We are very excited to … Continued

Memorial Healthcare System Joins the Caris Centers of Excellence for Precision Medicine Network

One of the Nation’s Largest Public Healthcare Systems Joins Caris Centers of Excellence for Precision Medicine Network to Advance Tumor Profiling and Broaden Access to Precision Medicine  IRVING, Texas, August 8, 2016 – Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced that Memorial Healthcare System, one … Continued

Caris Life Sciences Designates USC Norris Comprehensive Cancer Center A Caris Center of Excellence for Precision Medicine

USC Norris Comprehensive Cancer Center, a NCI-Designated Cancer Center, Joins the Caris Centers of Excellence for Precision Medicine Network to Advance the Clinical Utility of Tumor Profiling  IRVING, Texas, Aug. 1, 2016 – Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced the designation of USC Norris Comprehensive Cancer … Continued

1 2 3 14

About Our News

Search to find the latest new about Caris Molecular Intelligence®, sign up for news alerts, and be sure to follow us on social media.